Mei, H. E., Schmidt, S., & Dörner, T. (2012). Rationale of anti-CD19 immunotherapy: An option to target autoreactive plasma cells in autoimmunity. BioMed Central.
Chicago Style CitationMei, Henrik E., Stefanie Schmidt, i Thomas Dörner. Rationale of Anti-CD19 Immunotherapy: An Option to Target Autoreactive Plasma Cells in Autoimmunity. BioMed Central, 2012.
Cita MLAMei, Henrik E., Stefanie Schmidt, i Thomas Dörner. Rationale of Anti-CD19 Immunotherapy: An Option to Target Autoreactive Plasma Cells in Autoimmunity. BioMed Central, 2012.
Atenció: Aquestes cites poden no estar 100% correctes.